BBOT logo

BridgeBio Oncology Therapeutics Inc.

BBOT
Healthcare|Biotechnology|US
$2.04
-0.13 (-5.99%)
DCF Value
$11.88
Tangible Book / Share
$4036.18
Cash / Share
$2819.48
Next Earnings Report
Nov 11, 2026
EPS est. -$0.69
Financing Filings (last 12 months)
11
Shelf registrations / offering prospectuses — latest Sep 1, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (3)

Aug 2027
Est. completion
P1Non-Small Cell Lung Cancer
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
NCT06917079n=665
Nov 2028
Est. completion
P1Solid Tumor, Adult
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775n=392
Apr 2031
Est. completion
P1Non-small Cell Lung Cancer
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
NCT06343402n=350

Recent Press Releases

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Oct 12, 2026 · GlobeNewsWire
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
Sep 8, 2026 · GlobeNewsWire
BBOT to Participate in Upcoming Investor Healthcare Conferences
Sep 1, 2026 · GlobeNewsWire
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 11, 2026 · GlobeNewsWire
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
Aug 11, 2026 · GlobeNewsWire

SEC Filings (77)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Sep 10, 2026EFFECTDocumentIndex
Sep 8, 2026EFFECTDocumentIndex
Sep 8, 20268-KMaterial eventDocumentIndex
Sep 1, 2026S-3Shelf registrationDocumentIndex
Sep 1, 2026POS AMDocumentIndex
Aug 12, 2026424B3Offering prospectusDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Jul 6, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 22, 2026424B3Offering prospectusDocumentIndex
Jun 22, 20268-KMaterial eventDocumentIndex
May 13, 2026424B3Offering prospectusDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
May 6, 2026424B3Offering prospectusDocumentIndex
May 4, 2026EFFECTDocumentIndex
Apr 30, 2026POS AMDocumentIndex
Apr 29, 2026424B3Offering prospectusDocumentIndex
Apr 29, 20268-KMaterial eventDocumentIndex
Apr 28, 2026ARSAnnual report to holdersDocumentIndex
Apr 28, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 23, 2026424B3Offering prospectusDocumentIndex
Apr 23, 20268-KMaterial eventDocumentIndex
Mar 26, 2026424B3Offering prospectusDocumentIndex
Mar 26, 20268-KMaterial eventDocumentIndex
Mar 6, 2026424B3Offering prospectusDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Jan 7, 2026424B3Offering prospectusDocumentIndex
Jan 7, 2026424B3Offering prospectusDocumentIndex
Jan 7, 20268-KMaterial eventDocumentIndex
Jan 2, 2026S-8Employee stock planDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Oct 10, 2025S-8Employee stock planDocumentIndex
Sep 10, 2025EFFECTDocumentIndex